Sofosbuvir with pegylated interferon alfa-2a and ribavirin for treatment-naive patients with hepatitis C genotype-1 infection (ATOMIC): an open-label, randomised, multicentre phase 2 trial

Kris V. Kowdley, Eric Lawitz, Israel Crespo, Tarek Hassanein, Mitchell Davis, Michael DeMicco, David Bernstein, Nezam H. Afdhal, John M. Vierling, Stuart C. Gordon,

The Lancet · 2013 · 296 citations · 7 references

Concepts

References

7